GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
NPFFR1 |
NPFFR1, GPR147, NPFF1: Neuropeptide FF receptor 1 |
0.265 |
Evidence |
|
ZNF42 |
MZF1, MZF, ZNF42, ZSCAN6: Myeloid zinc finger 1 |
GFI1B |
GFI1B: Zinc finger protein Gfi-1b |
0.265 |
Evidence |
|
SIRPB1 |
SIRPB1: Signal regulatory protein beta-1 precursor |
HLA-DRB5 |
HLA-Dw12: Cell surface glycoprotein |
0.265 |
Evidence |
|
KCNV2 |
KCNV2: Potassium voltage-gated channel subfamily V member 2 |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
0.265 |
Evidence |
|
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
KLK5 |
KLK5, SCTE, UNQ570/PRO1132: Kallikrein-5 precursor |
0.265 |
Evidence |
|
ARL3 |
ARL3, ARFL3: ADP-ribosylation factor-like protein 3 |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
0.265 |
Evidence |
|
HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
TAPBPL |
TAPBPL: Tapasin-related protein precursor |
0.265 |
Evidence |
|
KCNJ3 |
KCNJ3, GIRK1: G protein-activated inward rectifier potassium channel 1 |
KCNJ2 |
KCNJ2, HIRK1: Inward rectifier potassium channel 2 |
0.265 |
Evidence |
|
SSX5 |
SSX5: Protein SSX5 |
SCAND2 |
SCAND2: SCAN domain-containing protein 2 |
0.265 |
Evidence |
|
HCN2 |
HCN2, BCNG2: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gate |
RYR1 |
|
0.265 |
Evidence |
|
GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
BRS3 |
BRS3: Bombesin receptor subtype-3 |
0.265 |
Evidence |
|
KCNA1 |
KCNA1: Potassium voltage-gated channel subfamily A member 1 |
SCN2A2 |
SCN2A, NAC2, SCN2A1, SCN2A2: Sodium channel protein type 2 subunit alpha |
0.265 |
Evidence |
|
ADAMTS2 |
ADAMTS2, PCINP, PCPNI: ADAMTS-2 precursor |
TIMP4 |
TIMP4: Metalloproteinase inhibitor 4 precursor |
0.265 |
Evidence |
|
CNTFR |
CNTFR: Ciliary neurotrophic factor receptor alpha precursor |
BSF3 |
CLCF1, BSF3, CLC, NNT1: Cardiotrophin-like cytokine factor 1 precursor |
0.265 |
Evidence |
O
|
CHRNA2 |
CHRNA2: Neuronal acetylcholine receptor subunit alpha-2 precursor |
HTR3A |
5-hydroxytryptamine |
0.265 |
Evidence |
|
HLA-DOA |
HLA-DOA, HLA-DNA, HLA-DZA: HLA class II histocompatibility antigen, DO alpha cha |
HLA-DRB5 |
HLA-Dw12: Cell surface glycoprotein |
0.265 |
Evidence |
|
BLR1 |
BLR1, CXCR5, MDR15: C-X-C chemokine receptor type 5 |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
0.265 |
Evidence |
|
TNFRSF13B |
TNFRSF13B, TACI: Tumor necrosis factor receptor superfamily member 13B |
TNF |
TNF, TNFA, TNFSF2: Tumor necrosis factor precursor |
0.265 |
Evidence |
|
SCAND2 |
SCAND2: SCAN domain-containing protein 2 |
ZNF283 |
ZNF283: Zinc finger protein 283 |
0.265 |
Evidence |
|
ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
IMPACT |
IMPACT: IMPACT protein |
0.265 |
Evidence |
|
ME1 |
ME1: NADP-dependent malic enzyme |
PSMD13 |
PSMD13: 26S proteasome non-ATPase regulatory subunit 13 |
0.265 |
Evidence |
|
YEATS4 |
YEATS4, GAS41: YEATS domain-containing protein 4 |
VPS72 |
VPS72, TCFL1, YL1: Vacuolar protein sorting-associated protein 72 homolog |
0.265 |
Evidence |
|
CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
KYNU |
KYNU: Kynureninase |
0.265 |
Evidence |
|
SORT1 |
SORT1: Sortilin precursor |
ELOVL5 |
ELOVL5, ELOVL2, PRO0530: Elongation of very long chain fatty acids protein 5 |
0.265 |
Evidence |
|
ACTG1 |
ACTR2, ARP2: Actin-related protein 2 |
ACTR3B |
ARP3beta, ACTR3B: Actin-like protein 3 homolog B |
0.265 |
Evidence |
|